Results 151 to 160 of about 684,037 (352)
Factors Influencing Care Trajectories for Common Mental Disorders related sick leave : Patients’ Experience in Primary Care [PDF]
, 2023 Justine Labourot
openalex +1 more source
Advanced Healthcare Materials, EarlyView.Next‐Generation Psoriasis Therapy – With advanced dendrimer‐based formulations, this study paves the way for highly effective, skin‐permeable treatments. Encapsulated in fluid catanionic vesicles, IMD‐006 and its analogues show promising anti‐psoriatic effects offering a targeted, non‐invasive approach to managing chronic skin inflammation.
Ranime Jebbawi +10 more
wiley +1 more source
Publikationer från Örebro universitet, 2013 Decisions on entitlement to sickness benefits and return to work interventions have substantial impact on individuals’ lives and on society. In most Western European countries, such decisions are based on sickness certificates, which should provide information on how a disease or injury reduces the individual’s work ability.
openaire +2 more sources
Advanced Healthcare Materials, EarlyView.Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales +11 more
wiley +1 more source
Part-time Sick Leave as a Treatment for Individuals with Mental Disorders? [PDF]
It has been suggested that using, when possible, part-time sick leave (PTSL) rather than full-time sick leave (FTSL) for employees diagnosed with a mental disorder (MD) decreases their likelihood of being on sick leave for long periods. However, no study
Andrén, Daniela
core
Low-Skill Jobs, Work Hours, and Paid Time Off [PDF]
, 2008 Based on a survey of employers, examines the scheduling demands placed on low-skill workers and the availability of sick leave, paid time off, and benefits allowing for the care of family members.
Gregory Acs, Pamela J. Loprest
core
Advanced Healthcare Materials, EarlyView.This study explores nanoparticle delivery of the protein kinase C inhibitor bisindolylmaleimide‐I (BIM‐I) to combat influenza A virus infections. Encapsulation in biodegradable PLGA nanoparticles improved safety while maintaining the compound's strong antiviral activity.
Laura Klement +12 more
wiley +1 more source